InsiderTrades

Form 4 for EAF GRAFTECH INTERNATIONAL LTD

Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001140361-24-000784 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-01-04 2024-01-02 EAF BCP IV (US Plan) LP Former 10% Owner S - Sale $2.20 -3.92M 23.35M -14% -$8.63M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-02 S D 1,038,919 $2.20 25,199,573 I See Explanation of Responses — — (F1) The sales reported in this Form 4 (the "Sales") were effected pursuant to Rule 144 under the Securities Act of 1933, as amended (the "Securities Act"). (F2) On January 2, 2024, the Reporting Persons sold an aggregate of 6,100,000 shares of Common Stock. Represents (i) 1,037,120 of Common Stock sold on behalf of BPE IV (Non-Cdn) GP LP; (ii) 1,038,919 shares of Common Stock sold on behalf of Brookfield BBP (Canada) L.P.; (iii) 1,846,591 shares of Common Stock sold on behalf of Brookfield BBP Canada Holdings Inc.; (iv) 88 shares of Common Stock sold on behalf of Brookfield Private Funds Holdings Inc.; (v) 68 shares of Common Stock sold on behalf of BCP IV Bermuda Investor LP and (vi) 2,177,214 shares of Common Stock sold by BCP GrafTech IV Holdings L.P. on behalf of certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F3) Following the Sales, consists of (i) 6,174,100 shares of Common Stock held directly by BPE IV (Non-Cdn) GP LP, for itself and as nominee for BCP IV (US Plan) LP, BCP IV (UK Plan) LP and BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP; (ii) 6,184,809 shares of Common Stock held directly by Brookfield BBP (Canada) L.P.; (iii) 10,992,990 shares of Common Stock held directly by Brookfield BBP Canada Holdings Inc.; (iv) 524 shares of Common Stock held directly by Brookfield Private Funds Holdings Inc.; and (v) 403 shares of Common Stock held directly by BCP IV Bermuda Investor LP. The amount of securities beneficially owned by the Reporting Persons does not include the shares of Common Stock distributed pro rata, for no consideration, on December 14, 2023 to certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F7) Brookfield Business L.P., Brookfield Business Partners L.P., Brookfield Business Partners Limited and BN, by virtue of their relationships with Brookfield BBP Canada Holdings Inc., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP Canada Holdings Inc. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BCP IV Bermuda Investor LP. (F6) Brookfield Private Equity Holdings LLC, Brookfield US Inc. and BN, by virtue of their relationships with BCP IV (US Plan) LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP as nominee for BCP IV (US Plan) LP. Brookfield BBP Canadian GP L.P., Brookfield CanGP Limited, Brookfield Private Equity Inc. and BN, by virtue of their relationships with Brookfield BBP (Canada) L.P., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP (Canada) L.P. (F8) Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. (F5) BPE IV (Non-Cdn) GP LP, Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV, may be deemed to share beneficial ownership in the shares held directly by BCP IV. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BPE IV (Non-Cdn) GP LP, BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP for itself and as nominee for BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP. (F4) Brookfield Corporation ("BN"), by virtue of its relationships with these entities, may be deemed to share beneficial ownership of all of these shares.
2 Common Common Stock 2024-01-02 S D 1,037,120 $2.20 26,238,492 I See Explanation of Responses — — (F1) The sales reported in this Form 4 (the "Sales") were effected pursuant to Rule 144 under the Securities Act of 1933, as amended (the "Securities Act"). (F2) On January 2, 2024, the Reporting Persons sold an aggregate of 6,100,000 shares of Common Stock. Represents (i) 1,037,120 of Common Stock sold on behalf of BPE IV (Non-Cdn) GP LP; (ii) 1,038,919 shares of Common Stock sold on behalf of Brookfield BBP (Canada) L.P.; (iii) 1,846,591 shares of Common Stock sold on behalf of Brookfield BBP Canada Holdings Inc.; (iv) 88 shares of Common Stock sold on behalf of Brookfield Private Funds Holdings Inc.; (v) 68 shares of Common Stock sold on behalf of BCP IV Bermuda Investor LP and (vi) 2,177,214 shares of Common Stock sold by BCP GrafTech IV Holdings L.P. on behalf of certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F3) Following the Sales, consists of (i) 6,174,100 shares of Common Stock held directly by BPE IV (Non-Cdn) GP LP, for itself and as nominee for BCP IV (US Plan) LP, BCP IV (UK Plan) LP and BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP; (ii) 6,184,809 shares of Common Stock held directly by Brookfield BBP (Canada) L.P.; (iii) 10,992,990 shares of Common Stock held directly by Brookfield BBP Canada Holdings Inc.; (iv) 524 shares of Common Stock held directly by Brookfield Private Funds Holdings Inc.; and (v) 403 shares of Common Stock held directly by BCP IV Bermuda Investor LP. The amount of securities beneficially owned by the Reporting Persons does not include the shares of Common Stock distributed pro rata, for no consideration, on December 14, 2023 to certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F7) Brookfield Business L.P., Brookfield Business Partners L.P., Brookfield Business Partners Limited and BN, by virtue of their relationships with Brookfield BBP Canada Holdings Inc., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP Canada Holdings Inc. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BCP IV Bermuda Investor LP. (F6) Brookfield Private Equity Holdings LLC, Brookfield US Inc. and BN, by virtue of their relationships with BCP IV (US Plan) LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP as nominee for BCP IV (US Plan) LP. Brookfield BBP Canadian GP L.P., Brookfield CanGP Limited, Brookfield Private Equity Inc. and BN, by virtue of their relationships with Brookfield BBP (Canada) L.P., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP (Canada) L.P. (F8) Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. (F5) BPE IV (Non-Cdn) GP LP, Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV, may be deemed to share beneficial ownership in the shares held directly by BCP IV. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BPE IV (Non-Cdn) GP LP, BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP for itself and as nominee for BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP. (F4) Brookfield Corporation ("BN"), by virtue of its relationships with these entities, may be deemed to share beneficial ownership of all of these shares.
3 Common Common Stock 2024-01-02 S D 68 $2.20 23,352,826 I See Explanation of Responses — — (F1) The sales reported in this Form 4 (the "Sales") were effected pursuant to Rule 144 under the Securities Act of 1933, as amended (the "Securities Act"). (F2) On January 2, 2024, the Reporting Persons sold an aggregate of 6,100,000 shares of Common Stock. Represents (i) 1,037,120 of Common Stock sold on behalf of BPE IV (Non-Cdn) GP LP; (ii) 1,038,919 shares of Common Stock sold on behalf of Brookfield BBP (Canada) L.P.; (iii) 1,846,591 shares of Common Stock sold on behalf of Brookfield BBP Canada Holdings Inc.; (iv) 88 shares of Common Stock sold on behalf of Brookfield Private Funds Holdings Inc.; (v) 68 shares of Common Stock sold on behalf of BCP IV Bermuda Investor LP and (vi) 2,177,214 shares of Common Stock sold by BCP GrafTech IV Holdings L.P. on behalf of certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F3) Following the Sales, consists of (i) 6,174,100 shares of Common Stock held directly by BPE IV (Non-Cdn) GP LP, for itself and as nominee for BCP IV (US Plan) LP, BCP IV (UK Plan) LP and BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP; (ii) 6,184,809 shares of Common Stock held directly by Brookfield BBP (Canada) L.P.; (iii) 10,992,990 shares of Common Stock held directly by Brookfield BBP Canada Holdings Inc.; (iv) 524 shares of Common Stock held directly by Brookfield Private Funds Holdings Inc.; and (v) 403 shares of Common Stock held directly by BCP IV Bermuda Investor LP. The amount of securities beneficially owned by the Reporting Persons does not include the shares of Common Stock distributed pro rata, for no consideration, on December 14, 2023 to certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F7) Brookfield Business L.P., Brookfield Business Partners L.P., Brookfield Business Partners Limited and BN, by virtue of their relationships with Brookfield BBP Canada Holdings Inc., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP Canada Holdings Inc. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BCP IV Bermuda Investor LP. (F6) Brookfield Private Equity Holdings LLC, Brookfield US Inc. and BN, by virtue of their relationships with BCP IV (US Plan) LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP as nominee for BCP IV (US Plan) LP. Brookfield BBP Canadian GP L.P., Brookfield CanGP Limited, Brookfield Private Equity Inc. and BN, by virtue of their relationships with Brookfield BBP (Canada) L.P., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP (Canada) L.P. (F8) Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. (F5) BPE IV (Non-Cdn) GP LP, Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV, may be deemed to share beneficial ownership in the shares held directly by BCP IV. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BPE IV (Non-Cdn) GP LP, BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP for itself and as nominee for BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP. (F4) Brookfield Corporation ("BN"), by virtue of its relationships with these entities, may be deemed to share beneficial ownership of all of these shares.
4 Common Common Stock 2024-01-02 S D 1,846,591 $2.20 23,352,982 I See Explanation of Responses — — (F1) The sales reported in this Form 4 (the "Sales") were effected pursuant to Rule 144 under the Securities Act of 1933, as amended (the "Securities Act"). (F2) On January 2, 2024, the Reporting Persons sold an aggregate of 6,100,000 shares of Common Stock. Represents (i) 1,037,120 of Common Stock sold on behalf of BPE IV (Non-Cdn) GP LP; (ii) 1,038,919 shares of Common Stock sold on behalf of Brookfield BBP (Canada) L.P.; (iii) 1,846,591 shares of Common Stock sold on behalf of Brookfield BBP Canada Holdings Inc.; (iv) 88 shares of Common Stock sold on behalf of Brookfield Private Funds Holdings Inc.; (v) 68 shares of Common Stock sold on behalf of BCP IV Bermuda Investor LP and (vi) 2,177,214 shares of Common Stock sold by BCP GrafTech IV Holdings L.P. on behalf of certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F3) Following the Sales, consists of (i) 6,174,100 shares of Common Stock held directly by BPE IV (Non-Cdn) GP LP, for itself and as nominee for BCP IV (US Plan) LP, BCP IV (UK Plan) LP and BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP; (ii) 6,184,809 shares of Common Stock held directly by Brookfield BBP (Canada) L.P.; (iii) 10,992,990 shares of Common Stock held directly by Brookfield BBP Canada Holdings Inc.; (iv) 524 shares of Common Stock held directly by Brookfield Private Funds Holdings Inc.; and (v) 403 shares of Common Stock held directly by BCP IV Bermuda Investor LP. The amount of securities beneficially owned by the Reporting Persons does not include the shares of Common Stock distributed pro rata, for no consideration, on December 14, 2023 to certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F7) Brookfield Business L.P., Brookfield Business Partners L.P., Brookfield Business Partners Limited and BN, by virtue of their relationships with Brookfield BBP Canada Holdings Inc., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP Canada Holdings Inc. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BCP IV Bermuda Investor LP. (F6) Brookfield Private Equity Holdings LLC, Brookfield US Inc. and BN, by virtue of their relationships with BCP IV (US Plan) LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP as nominee for BCP IV (US Plan) LP. Brookfield BBP Canadian GP L.P., Brookfield CanGP Limited, Brookfield Private Equity Inc. and BN, by virtue of their relationships with Brookfield BBP (Canada) L.P., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP (Canada) L.P. (F8) Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. (F5) BPE IV (Non-Cdn) GP LP, Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV, may be deemed to share beneficial ownership in the shares held directly by BCP IV. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BPE IV (Non-Cdn) GP LP, BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP for itself and as nominee for BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP. (F4) Brookfield Corporation ("BN"), by virtue of its relationships with these entities, may be deemed to share beneficial ownership of all of these shares.
5 Common Common Stock 2024-01-02 S D 88 $2.20 23,352,894 I See Explanation of Responses — — (F1) The sales reported in this Form 4 (the "Sales") were effected pursuant to Rule 144 under the Securities Act of 1933, as amended (the "Securities Act"). (F2) On January 2, 2024, the Reporting Persons sold an aggregate of 6,100,000 shares of Common Stock. Represents (i) 1,037,120 of Common Stock sold on behalf of BPE IV (Non-Cdn) GP LP; (ii) 1,038,919 shares of Common Stock sold on behalf of Brookfield BBP (Canada) L.P.; (iii) 1,846,591 shares of Common Stock sold on behalf of Brookfield BBP Canada Holdings Inc.; (iv) 88 shares of Common Stock sold on behalf of Brookfield Private Funds Holdings Inc.; (v) 68 shares of Common Stock sold on behalf of BCP IV Bermuda Investor LP and (vi) 2,177,214 shares of Common Stock sold by BCP GrafTech IV Holdings L.P. on behalf of certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F3) Following the Sales, consists of (i) 6,174,100 shares of Common Stock held directly by BPE IV (Non-Cdn) GP LP, for itself and as nominee for BCP IV (US Plan) LP, BCP IV (UK Plan) LP and BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP; (ii) 6,184,809 shares of Common Stock held directly by Brookfield BBP (Canada) L.P.; (iii) 10,992,990 shares of Common Stock held directly by Brookfield BBP Canada Holdings Inc.; (iv) 524 shares of Common Stock held directly by Brookfield Private Funds Holdings Inc.; and (v) 403 shares of Common Stock held directly by BCP IV Bermuda Investor LP. The amount of securities beneficially owned by the Reporting Persons does not include the shares of Common Stock distributed pro rata, for no consideration, on December 14, 2023 to certain third party limited partners in which the Reporting Persons do not have a pecuniary interest. (F7) Brookfield Business L.P., Brookfield Business Partners L.P., Brookfield Business Partners Limited and BN, by virtue of their relationships with Brookfield BBP Canada Holdings Inc., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP Canada Holdings Inc. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BCP IV Bermuda Investor LP. (F6) Brookfield Private Equity Holdings LLC, Brookfield US Inc. and BN, by virtue of their relationships with BCP IV (US Plan) LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP as nominee for BCP IV (US Plan) LP. Brookfield BBP Canadian GP L.P., Brookfield CanGP Limited, Brookfield Private Equity Inc. and BN, by virtue of their relationships with Brookfield BBP (Canada) L.P., may be deemed to share beneficial ownership in the shares held directly by Brookfield BBP (Canada) L.P. (F8) Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. (F5) BPE IV (Non-Cdn) GP LP, Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BCP IV, may be deemed to share beneficial ownership in the shares held directly by BCP IV. Brookfield Capital Partners Ltd., BCP GP Limited, Brookfield Private Equity Group Holdings LP, Brookfield Private Equity Inc. and BN, by virtue of their relationships with BPE IV (Non-Cdn) GP LP, BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP, may be deemed to share beneficial ownership in the shares held directly by BPE IV (Non-Cdn) GP LP for itself and as nominee for BCP IV (UK Plan) LP, BCP IV (Cdn Plan) LP and BCP IV Bermuda Investor LP. (F4) Brookfield Corporation ("BN"), by virtue of its relationships with these entities, may be deemed to share beneficial ownership of all of these shares.